Skip to content

An assessment of arterial stiffness, oxidative stress and inflammation in acute kidney injury

An assessment of arterial stiffness, oxidative stress and inflammation in acute kidney injury

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12609000285257
Enrollment
90
Registered
2009-05-18
Start date
2009-06-15
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Vascular disease, characterised by premature atherosclerosis and large artery stiffness, is a feature of advanced chronic kidney disease (CKD) [1, 2]. Central pulse pressure, augmentation index (AIx) and aortic pulse wave velocity (PWV) are all predictors of morbidity and mortality in patients with CKD [1, 3, 4]. Large artery stiffness may also be related to the progression of CKD. The mechanisms and time frames for the development of arterial stiffness are unclear but may include traditional cardiovascular risk factors such as dyslipidemia and hypertension as well as non-traditional risk factors such as oxidative stress and inflammation. Moreover, to our knowledge no studies have assessed the relationship between arterial stiffness in the uraemic environment of acute kidney injury. Measuring arterial stiffness in this setting would enable us to determine whether changes in arterial stiffness occur due to the biochemical changes associated with acute kidney injury without the interference of factors that exist in chronic kidney disease. This may in turn help to understand the potential for reversibility of uremic biochemical effects on arterial stiffness.

Interventions

Arterial stiffness will be measured with pulse wave velocity, augmentation index together with oxidative stress (F2 isoprostanes) and inflammation(pentraxin-3). These will be measured on presentation with acute kidney injury and then at six and 12 months after

Sponsors

Royal Brisbane and Women's Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

Creatinine >133 umol/l or urea > 14.3 mmol/l or oliguria with urine output < 410 ml/day

Exclusion criteria

Already receiving dialysis or hemofiltration Receiving ionotropic agents

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026